Butanoic acid, 2,2-dimethyl-, (1R,3R,4aS,7R,8R,8aR)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2S,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, rel-
- CAS NO.：2731620-64-5
- Empirical Formula: C25H40O5
- Molecular Weight: 420.59
- Update Date: 2023-07-12 16:52:09
![Butanoic acid, 2,2-dimethyl-, (1R,3R,4aS,7R,8R,8aR)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2S,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, rel- Structural](https://img.chemicalbook.in/CAS/20211123/GIF/2731620-64-5.gif)
Properties of Butanoic acid, 2,2-dimethyl-, (1R,3R,4aS,7R,8R,8aR)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2S,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, rel-
| Boiling point: | 541.5±50.0 °C(Predicted) |
| Density | 1.09±0.1 g/cm3(Predicted) |
| pka | 13.49±0.40(Predicted) |
Safety information for Butanoic acid, 2,2-dimethyl-, (1R,3R,4aS,7R,8R,8aR)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2S,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, rel-
Computed Descriptors for Butanoic acid, 2,2-dimethyl-, (1R,3R,4aS,7R,8R,8aR)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2S,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, rel-
Butanoic acid, 2,2-dimethyl-, (1R,3R,4aS,7R,8R,8aR)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2S,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, rel- manufacturer
GLP Pharma Standards
3Y
Phone:+91-7893074638
Whatsapp: +91-7893074638
product: Simvastatin EP Impurity K 2731620-64-5 NLT 95%
New Products
Paroxetine Impurity G/Paroxetine Related Compound E 2-Amino-5-bromo-4-(trifluoromethyl)pyridine（RM for Indian lab) 1-aminocyclopentane carbonitrile, HCl H-D-TRP(FOR)-OH HCL 9-Mesityl-10-methylacridinium perchlorate 3-Amino-3-(4-fluorophenyl)propanoic acid Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate Bisacodyl Related Compound C/Bisacodyl EP Impurity C Levothyroxine Beta Hydroxy Impurity Candesartan EP Impurity-F/Candesartan Cilexetil USP Related Compound F / Candesartan Cilexetil N2-Ethyl Impurity / 2H-N2-Ethyl Candesartan Cilexetil Atorvastatin amide impurity/Atorvastatin EP Impurity F(Calcium Salt) Sumatriptan Succinate USP Related Compound C N-[(1S)-1-benzyl-2-({(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]-2-pyrazinecarboxamide N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropionamide L-phenylalanine methyl ester hydrochloride 2,2'-(5-Bromomethyl-1,3-phenylene)-di(2-Methylpropionitrile) tri sodium thio phosphate L-phenylalanine, N-(pyrazinyl carbonyl) methyl ester 3-chlorobenzyl cyanide 2-Chloro Benzylcyanide 3,4 Diethoxy Benzylcyanide 4-Bromo Benzylcyanide 3-Hydroxypropionitrile valeronitrileYou may like
-
Simvastatin EP Impurity K 2731620-64-5 NLT 95%View Details
2731620-64-5 -
1012886-75-7(HCl Salt)/69675-10-1(Freebase) Paroxetine Impurity G/Paroxetine Related Compound E NLT 95%View Details
1012886-75-7(HCl Salt)/69675-10-1(Freebase) -
110-59-8 valeronitrile 99%View Details
110-59-8 -
93-17-4 99%View Details
93-17-4 -
1529-41-5 3-chlorobenzyl cyanide 99%View Details
1529-41-5 -
2856-63-5 99%View Details
2856-63-5 -
3,4 Diethoxy Benzylcyanide 99%View Details
27472-21-5 -
2847776-12-7 Sumatriptan Succinate USP Related Compound C NLT 95%View Details
2847776-12-7
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.